BFLY Quote, Financials, Valuation and Earnings

Adagio Medical Holdings, Inc. has a net margin of -158.09% compared to Butterfly Network, Inc.'s net margin of --. Butterfly Network, Inc.'s return on equity of -38.89% beat Adagio Medical Holdings, Inc.'s return on equity of -340.49%.

Butterfly Network, Inc. has a consensus price target of $4.19, signalling upside risk potential of 3.65%. On the other hand Adagio Medical Holdings, Inc. has an analysts' consensus of $4.00 which suggests that it could grow by 312.29%. Given that Adagio Medical Holdings, Inc. has higher upside potential than Butterfly Network, Inc., analysts believe Adagio Medical Holdings, Inc. is more attractive than Butterfly Network, Inc..

Butterfly Network, Inc. has a beta of 2.269, which suggesting that the stock is 126.856% more volatile than S&P 500. In comparison Adagio Medical Holdings, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Butterfly Network, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Adagio Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Butterfly Network, Inc. pays -- of its earnings as a dividend. Adagio Medical Holdings, Inc. pays out -- of its earnings as a dividend.

Butterfly Network, Inc. quarterly revenues are $21.5M, which are larger than Adagio Medical Holdings, Inc. quarterly revenues of --. Butterfly Network, Inc.'s net income of -$34M is lower than Adagio Medical Holdings, Inc.'s net income of -$10.1M. Notably, Butterfly Network, Inc.'s price-to-earnings ratio is -- while Adagio Medical Holdings, Inc.'s PE ratio is 218.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Butterfly Network, Inc. is 10.83x versus 108.59x for Adagio Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Intelligent Bio Solutions, Inc. has a net margin of -158.09% compared to Butterfly Network, Inc.'s net margin of -269.38%. Butterfly Network, Inc.'s return on equity of -38.89% beat Intelligent Bio Solutions, Inc.'s return on equity of -255.54%.

Butterfly Network, Inc. has a consensus price target of $4.19, signalling upside risk potential of 3.65%. On the other hand Intelligent Bio Solutions, Inc. has an analysts' consensus of -- which suggests that it could grow by 569.64%. Given that Intelligent Bio Solutions, Inc. has higher upside potential than Butterfly Network, Inc., analysts believe Intelligent Bio Solutions, Inc. is more attractive than Butterfly Network, Inc..

Butterfly Network, Inc. has a beta of 2.269, which suggesting that the stock is 126.856% more volatile than S&P 500. In comparison Intelligent Bio Solutions, Inc. has a beta of 4.455, suggesting its more volatile than the S&P 500 by 345.491%.

Butterfly Network, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Intelligent Bio Solutions, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Butterfly Network, Inc. pays -- of its earnings as a dividend. Intelligent Bio Solutions, Inc. pays out -- of its earnings as a dividend.

Butterfly Network, Inc. quarterly revenues are $21.5M, which are larger than Intelligent Bio Solutions, Inc. quarterly revenues of $1.1M. Butterfly Network, Inc.'s net income of -$34M is lower than Intelligent Bio Solutions, Inc.'s net income of -$3M. Notably, Butterfly Network, Inc.'s price-to-earnings ratio is -- while Intelligent Bio Solutions, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Butterfly Network, Inc. is 10.83x versus 35.62x for Intelligent Bio Solutions, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Standard BioTools, Inc. has a net margin of -158.09% compared to Butterfly Network, Inc.'s net margin of -162.05%. Butterfly Network, Inc.'s return on equity of -38.89% beat Standard BioTools, Inc.'s return on equity of -24.44%.

Butterfly Network, Inc. has a consensus price target of $4.19, signalling upside risk potential of 3.65%. On the other hand Standard BioTools, Inc. has an analysts' consensus of $1.55 which suggests that it could grow by 0.65%. Given that Butterfly Network, Inc. has higher upside potential than Standard BioTools, Inc., analysts believe Butterfly Network, Inc. is more attractive than Standard BioTools, Inc..

Butterfly Network, Inc. has a beta of 2.269, which suggesting that the stock is 126.856% more volatile than S&P 500. In comparison Standard BioTools, Inc. has a beta of 1.264, suggesting its more volatile than the S&P 500 by 26.42%.

Butterfly Network, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Standard BioTools, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Butterfly Network, Inc. pays -- of its earnings as a dividend. Standard BioTools, Inc. pays out -- of its earnings as a dividend.

Butterfly Network, Inc. quarterly revenues are $21.5M, which are larger than Standard BioTools, Inc. quarterly revenues of $19.6M. Butterfly Network, Inc.'s net income of -$34M is lower than Standard BioTools, Inc.'s net income of -$31.7M. Notably, Butterfly Network, Inc.'s price-to-earnings ratio is -- while Standard BioTools, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Butterfly Network, Inc. is 10.83x versus 4.53x for Standard BioTools, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

LENSAR, Inc. has a net margin of -158.09% compared to Butterfly Network, Inc.'s net margin of -25.94%. Butterfly Network, Inc.'s return on equity of -38.89% beat LENSAR, Inc.'s return on equity of -1013.45%.

Butterfly Network, Inc. has a consensus price target of $4.19, signalling upside risk potential of 3.65%. On the other hand LENSAR, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 29.65%. Given that LENSAR, Inc. has higher upside potential than Butterfly Network, Inc., analysts believe LENSAR, Inc. is more attractive than Butterfly Network, Inc..

Butterfly Network, Inc. has a beta of 2.269, which suggesting that the stock is 126.856% more volatile than S&P 500. In comparison LENSAR, Inc. has a beta of 0.695, suggesting its less volatile than the S&P 500 by 30.495%.

Butterfly Network, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. LENSAR, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Butterfly Network, Inc. pays -- of its earnings as a dividend. LENSAR, Inc. pays out -- of its earnings as a dividend.

Butterfly Network, Inc. quarterly revenues are $21.5M, which are larger than LENSAR, Inc. quarterly revenues of $14.3M. Butterfly Network, Inc.'s net income of -$34M is lower than LENSAR, Inc.'s net income of -$3.7M. Notably, Butterfly Network, Inc.'s price-to-earnings ratio is -- while LENSAR, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Butterfly Network, Inc. is 10.83x versus 2.32x for LENSAR, Inc.. Usually stocks with elevated PS ratios are considered overvalued.